ZTS FY 2021 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena

ZTSZoetis Inc.

$54B

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$7.8B+16.5% YoY

Gross Profit

$5.3B68.3% margin

Operating Income

$2.8B36.0% margin

Net Income

$2.0B26.2% margin

EPS (Diluted)

$4.27

Cash Flow

Operating Cash Flow

$2.2B

Free Cash Flow

$1.7B

Stock-Based Comp.

$58M

Balance Sheet

Total Assets

$13.9B

Total Liabilities

$9.4B

Stockholders' Equity

$4.5B

Cash & Equivalents

$3.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7.8B	$6.7B	+16.5%
Gross Profit	$5.3B	$4.5B	+19.2%
Operating Income	$2.8B	$2.3B	+23.5%
Net Income	$2.0B	$1.6B	+24.4%